{
  "claims": [
    {
      "claim_id": "C01",
      "claim": "Intratumoral mRNA vaccination triggers local innate sensing and type I interferon signaling.",
      "strength": "strong",
      "evidence": [
        {
          "quote": "The paper investigates whether intratumoral delivery of an mRNA vaccine can create an interferon-rich inflammatory state that improves sensitivity to anti-PD-L1 therapy.",
          "line_ref": "L11"
        },
        {
          "quote": "Type I interferon response score (normalized units): 3.1",
          "line_ref": "L31"
        },
        {
          "quote": "Blocking type I interferon signaling with anti-IFNAR1 eliminated the observed sensitization benefit.",
          "line_ref": "L39"
        }
      ],
      "caveat": "The mechanistic readouts were strongest in specific model systems rather than uniformly across all tested settings."
    },
    {
      "claim_id": "C02",
      "claim": "Interferon-associated antigen processing and presentation pathways increase after mRNA vaccination.",
      "strength": "strong",
      "evidence": [
        {
          "quote": "Fraction of tumor proteins represented in immunopeptidome: 62.3%",
          "line_ref": "L28"
        },
        {
          "quote": "Fraction of proteins represented in MHC-I peptidome: 40.6%",
          "line_ref": "L29"
        },
        {
          "quote": "Interferon-associated antigen processing and presentation pathways increase.",
          "line_ref": "L43"
        }
      ],
      "caveat": "Some mechanistic readouts were strongest in specific model systems rather than uniformly across all tested settings."
    },
    {
      "claim_id": "C03",
      "claim": "A broader peptide repertoire appears on MHC-I, improving tumor visibility to T cells.",
      "strength": "moderate",
      "evidence": [
        {
          "quote": "Fraction of proteins represented in MHC-I peptidome: 40.6%",
          "line_ref": "L29"
        },
        {
          "quote": "A broader peptide repertoire appears on MHC-I, improving tumor visibility to T cells.",
          "line_ref": "L44"
        }
      ],
      "caveat": "The expansion of MHC-I-presented landscape was demonstrated in preclinical models but may not directly translate to all human tumor types."
    },
    {
      "claim_id": "C04",
      "claim": "PD-L1 pathway activity increases, creating a rationale for combining with checkpoint blockade.",
      "strength": "strong",
      "evidence": [
        {
          "quote": "PD-L1 expression fold-change in tumor tissue: 2.4x",
          "line_ref": "L32"
        },
        {
          "quote": "PD-L1 pathway activity also increases, creating a rationale for combining with checkpoint blockade.",
          "line_ref": "L45"
        }
      ],
      "caveat": "Increased PD-L1 expression was observed but the clinical benefit depends on proper timing and patient selection."
    },
    {
      "claim_id": "C05",
      "claim": "Combined intratumoral mRNA vaccine and anti-PD-L1 therapy improves tumor control in mice.",
      "strength": "strong",
      "evidence": [
        {
          "quote": "Preclinical arm: multiple murine tumor models with intratumoral mRNA vaccine and anti-PD-L1 combinations.",
          "line_ref": "L14"
        },
        {
          "quote": "Intratumoral CD8+ T-cell density fold-change: 1.8x",
          "line_ref": "L33"
        },
        {
          "quote": "Combined intervention improves tumor control in mice",
          "line_ref": "L46"
        }
      ],
      "caveat": "Mouse model effects may not map one-to-one to all human tumors due to differences in immunology and tumor microenvironment."
    },
    {
      "claim_id": "C06",
      "claim": "Retrospective human cohort analysis shows vaccinated patients had improved survival under ICI treatment.",
      "strength": "moderate",
      "evidence": [
        {
          "quote": "Human retrospective metastatic cohort: 130 patients total",
          "line_ref": "L21"
        },
        {
          "quote": "Human vaccinated subgroup: 43 patients",
          "line_ref": "L22"
        },
        {
          "quote": "Retrospective human survival comparison p-value: p=0.01",
          "line_ref": "L30"
        }
      ],
      "caveat": "The human analysis is retrospective and non-randomized; residual confounding is likely and vaccination timing varied across patients."
    }
  ]
}